1996Unpublished venueRequires access

Blood volume changes after long-term correction of anemia with recombinant human erythropoietin(EPO)in patients on maintenance hemodialysis

Nedeljko Topuzović, Vesna Rupčić, Aleksandar Rusić, Branislav Krstonošić, Ivan Karner

Open publisher page 0 citations

Abstract

The purpose of this study was to evaluate blood volume changes in chronic hemodialysis patients after long-term correction of anemia with recombinant human erythropoietin(EPO). Twenty three patients(12 males, 11 females, mean age 38+/-10 years) with severe renal anemia(hematocrit<0, 25) and on hemodialysis(mean duration 5.8+/- 3.7 years) were studied: 1)basally, before EPO treatment ; 2)short-term, at the time when target hemoglobin(Hg) reached 100g/l ; and 3)long-term, after 12 months of therapy.Blood volume was measured with Tc-99m-labeled human serum albumin using the method adjusted and validated in our laboratory.

About this research paper

What this paper is about

The purpose of this study was to evaluate blood volume changes in chronic hemodialysis patients after long-term correction of anemia with recombinant human erythropoietin(EPO). Twenty three patients(12 males, 11 females, mean age 38+/-10 years) with severe renal anemia(hematocrit<0, 25) and on hemodialysis(mean duration 5.8+/- 3.7 years) were studied: 1)basally, before EPO treatment ; 2)short-term, at the time when target hemoglobin(Hg) reached 100g/l ; and 3)long-term, after 12 months of therapy.Blood volume was measured with Tc-99m-labeled human serum albumin using the method adjusted and validated in our laboratory.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The purpose of this study was to evaluate blood volume changes in chronic hemodialysis patients after long-term correction of anemia with recombinant human erythropoietin(EPO). Twenty three patients(12 males, 11 females, mean age 38+/-10 years) with severe renal anemia(hematocrit<0, 25) and on hemodialysis(mean duration 5.8+/- 3.7 years) were studied: 1)basally, before EPO treatment ; 2)short-term, at the time when target hemoglobin(Hg) reached 100g/l ; and 3)long-term, after 12 months of therapy.Blood volume was measured with Tc-99m-labeled human serum albumin using the method adjusted and validated in our laboratory.

Key concepts: Erythropoietin, Hematocrit, Hemodialysis, Anemia, Medicine, Hemoglobin, Blood volume, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Blood volume changes after long-term correction of anemia with recombinant human erythropoietin(EPO)in patients on maintenance hemodialysis — Research Paper | ScholarLens